Bilateral lung volume reduction surgery was introduced into Australia in 1995 for treatment of selected patients with emphysema. We present our experience of the anaesthetic management of our first 55 cases and describe factors associated with outcome. There were four postoperative deaths (7%). Mean (SD) total operation time was 231 (72) minutes. Median intensive care unit (ICU) stay was 26 hours. There was a significant improvement in postoperative lung function (FEV 1 , VC, all P<0.001). Eight patients (15%) required reintubation for respiratory failure; three of these patients subsequently died. With multivariate analysis, total operation time was the only significant predictor of length of ICU stay R 2 =0.25, P=0.001), which itself was the only significant predictor of hospital stay duration (R 2 =0.36, P<0.001).
Bilateral lung volume reduction surgery via median sternotomy was originally described in 1958 but was reintroduced into clinical practice as treatment for diffuse (usually smoking-related) emphysema in 1993. Non-anatomic resection of apical portions of both upper lobes is performed with reinforcement of the suture line using strips of modified bovine pericardium. Improved surgical, anaesthetic and perioperative management has led to an acceptable mortality of 4% 1 .
The anaesthetic management of these patients is challenging. Lung volume reduction surgery requires one-lung ventilation in patients with severe airflow limitation. There is risk of hypoxia, dynamic hyperinflation or "gas trapping" affecting the circulation, and pain-derived impairment of postoperative respiratory function. Early awakening and extubation are primary goals of anaesthetic management in order to avoid postoperative positive pressure ventilation. This requires modification of the anaesthetic technique and optimal analgesia. High thoracic epidurals and the avoidance of sedating premedication and opioids have been advocated as part of anaesthetic care, yet, although intuitively logical, there has been no demonstration that this contributes to an improved outcome [1] [2] [3] [4] .
Lung volume reduction surgery was commenced at our institution in 1995 after extensive experience with lung transplantation. In this report we describe the anaesthetic management of our first 55 patients, aiming to detect factors that may predict adverse early clinical outcomes.
MATERIALS AND METHODS
This study received Institutional Ethics Committee approval. The selection criteria for lung volume reduction surgery were rigorous. Patients had to have severe emphysema demonstrated on pulmonary function testing without evidence of pulmonary hypertension and no other major co-morbidity. They had to be less than 75 years of age, a non-smoker for at least three months and a participant in a preoperative pulmonary rehabilitation program. Non-invasive pulmonary artery pressures were estimated in all patients with Doppler echocardiography, and patients were excluded if estimated pulmonary artery pressure exceeded 50 mmHg. Suitability for surgical resection rested on the finding of predominantly upper lobe emphysema with relatively preserved basal function on ventilation/perfusion (V/Q) and high resolution CT scanning. Surgery was performed when the patient was in optimal medical condition. Further details of patient selection and preoperative preparation have been previously published 5 .
Preoperative consultation by the anaesthetist included explanation of the anaesthetic procedures to be performed with particular emphasis on the benefits and risks of thoracic epidural analgesia. Premedication was at the discretion of the anaesthetist. On arrival in the operating room, patients had intravascular catheters (intravenous, intra-arterial, pulmonary arterial or central venous) and a thoracic epidural catheter inserted. Light intravenous sedation with midazolam was used if required during invasive procedures. Test dosing and timing for establishment of a block were at the anaesthetist's preference. Intraoperative hydrocortisone was administered to patients on preoperative steroid therapy.
Anaesthesia was induced most commonly with fentanyl 2 to 3 µg/kg and then propofol 2 to 2.5 mg/kg (or thiopentone 3 to 5 mg/kg). Muscle relaxation to facilitate intubation was provided by atracurium 0.5 mg/kg, vecuronium 0.1 mg/kg or rocuronium 0.6 mg/kg. Maintenance of anaesthesia was either volatile-based (isoflurane or sevoflurane) or with a titrated propofol infusion 6 to 12 mg/kg/hr. Oral endobronchial intubation was achieved with a leftsided Broncocath double-lumen tube (Mallinckrodt, Ireland). Its correct placement was confirmed by fibreoptic bronchoscopy. Patients were mechanically ventilated with oxygen/air; nitrous oxide was avoided. Oxygen 100% was used prior to one-lung ventilation. A forced air warming device was applied below the costal margins and nasopharyngeal temperature was monitored.
Ventilation management was aimed at reducing the risk of dynamic hyperinflation and consequent hypotension, barotrauma or disruption of staple lines contributing to air leak. When volume-controlled ventilation was used, reduced tidal volumes with pressurelimiting and long expiratory times with I:E ratios of at least 1:4 were employed. With the purchase of new anaesthetic workstations after the first 17 procedures, pressure-controlled ventilation became available (Ohmeda 7900 ventilator, Ohmeda Inc., Madison WI, U.S.A.) simplifying ventilator management. A pressure setting of 20 to 25 cmH 2 O with an I:E ratio of 1:4 and respiratory rate of 8 to 12 produced satisfactory alveolar ventilation without pulmonary injury in most patients.
One-lung ventilation was established and surgery was performed via median sternotomy. Up to 50% of both upper lobes were resected non-anatomically and the lung margins sealed with a linear stapler and reinforced with strips of modified bovine pericardium (Peristrips, Biovascular Inc, Saint Paul, MN, U.S.A.) 5 . There was rarely any difficulty with oxygenation during one-lung ventilation. Careful reinflation of the residual lung was employed to prevent tearing around staple lines and the sequelae of postoperative air leak. The surgeons routinely sited two intercostal catheters to each pleural cavity and infiltrated the exit sites with 0.5% bupivacaine; these were not placed on suction.
At the end of surgery neuromuscular blockade was reversed if necessary. Patients were transferred onto their beds and placed in a sitting position. Patients were extubated when they were comfortable and had an adequate spontaneous ventilatory pattern, rate and tidal volumes. They were then transferred to the ICU for observation. Humidified oxygen was administered through a facemask and baseline arterial blood gases were taken on arrival. Epidural analgesia was optimized during this period and was supplemented by indomethacin or diclofenac suppositories (100 mg b.d.) and regular paracetamol. The Acute Pain Service continued pain management thereafter with the patient being reviewed at least twice daily. Other postoperative management included early bronchodilator treatment (including ipratropium), physiotherapy and an erect chest X-ray to assess lung reinflation.
All patient and perioperative data were collected retrospectively from individual medical records and entered on a computer database for later analysis. Total operation time includes the time taken for anaesthetic preparation of the patient, surgical time and time taken at the end of the operation until extubation of the patient in the operating room and their delivery to the ICU. Descriptive data are presented as mean (SD), median (range) or number (%). Association between specific perioperative factors (patient, surgical and anaesthetic) and duration of ICU and hospital stay and requirement for reintubation were measured using Pearson correlation (r) or Spearman rank correlation (rho). Major variables considered included patient preoperative respiratory function tests, total operation time, doses of fentanyl and midazolam, and initial post extubation P a CO 2 . Intergroup comparisons were analysed using 504 A. U. BUETTNER, R. MCRAE ET AL Student's t test. Exploratory multivariate analyses were also made. Statistical analyses were performed using a computer statistical package SPSS V4.0. A P value of less than 0.05 was considered significant.
RESULTS
Between September 1995 and January 1998, 55 patients (18 men, 37 women), aged 61.1 years (range 42-76 years) underwent bilateral lung volume reduction surgery. All had lung functional characteristics of severe emphysema with marked hyperinflation and reduced forced expiratory volumes ( Table 1) . Every patient had a history of tobacco use but had ceased smoking at least three months prior to surgery. All patients received regular inhaled β 2 adrenergic agonist medication and most used inhaled ipratropium bromide. Twenty-three (42%) were on oral steroids and nine (16%) received domiciliary oxygen therapy. Seventeen patients (31%) were treated for other medical conditions, most commonly for hypertension (n=10).
Total operation time was 231 (72) min (range 150-620 min). Approximately one hour was spent preparing the patient before surgery and 30 minutes spent afterwards in preparation for extubation. All but two patients were extubated in the operating room. These two patients both had prolonged surgical procedures (>6 hours). One of them sustained a traumatic right phrenic nerve palsy intraoperatively and required long-term respiratory support and a permanent tracheostomy. The other patient had a difficult operative course due to multiple adhesions with the development of persistent air leak and a pneumothorax.
Initial post-extubation arterial blood gases demonstrated impaired oxygenation and mild moderate respiratory acidosis (when compared with preoperative values, P a O 2 /FiO 2 , P a CO 2 all P<0.001) ( Table 2) .
Seventeen patients (31%) required reintubation during their postoperative course ( Table 3 ). Eight (15%) of these were for respiratory failure associated with sputum retention, air leak and difficulties with pain control. Three of these patients subsequently died. Nine patients (16%) were intubated following a return to the operating room for further surgery (mostly for oversew of air leak). One patient developed an acute abdomen secondary to a perforated duodenal ulcer and gangrenous cholecystitis. Length of initial intensive care unit stay was a median of 26 hours (range 7-3042 hours). Ten patients required a subsequent ICU admission following reintubation for either respiratory failure or following further surgery. The median hospital stay was 13 days. Fifty-one patients (93%) survived to hospital discharge. There were no late deaths at up to three-year follow-up.
Fifty-four patients had a thoracic epidural catheter inserted through a Tuohy needle at a median level of T 5/6 (range T 2/3-T 9/10). All epidurals were used intraoperatively with a median dose of 6.0 ml 0.5% bupivacaine administered (range 0-30ml). Epidural infusions of bupivacaine 0.125% and fentanyl 2 µg/ml (69%), bupivacaine 0.125% and fentanyl 1 µg/ml (13%) or plain bupivacaine 0.125% (16%), were continued postoperatively for a mean of 4.6 (1.7) days (range 0-8 days).
Thirteen patients had unsatisfactory epidural analgesia within the first postoperative 24 hours (as indicated by the need for more than three epidural boluses to ensure an adequate block). Four of these responded to further boluses of bupivacaine 0.25% or 0.5%. Three patients required epidural resiting, three 505 ANAESTHESIA FOR LUNG VOLUME REDUCTION SURGERY Anaesthesia and Intensive Care, Vol. 27, No. 5, October 1999 had an IV morphine infusion added to a plain bupivacaine epidural, two epidurals were abandoned and IV morphine infusions were used and one had epidural fentanyl added to a plain bupivacaine infusion. One patient in whom several attempts at epidural insertion were unsuccessful had a morphine infusion as his primary mode of analgesia. One patient who had needed reintubation for respiratory failure required a series of four epidural catheters to be inserted. Ten days postoperatively blood was aspirated during an epidural insertion and the patient developed a flaccid paralysis. An MRI showed an epidural haematoma and subsequent urgent surgery showed that this was due to perforation of an unknown epidural arteriovenous malformation. Despite surgery, the patient developed a spastic paraparesis. This patient ultimately died on day 28 from sepsis and multiorgan failure unrelated to the epidural complication. The other significant epiduralrelated complication was one patient who inadvertently received a 60 ml bolus of epidural infusion solution (bupivacaine 0.125% fentanyl 2µg/ml) on the ward. This patient was admitted to ICU and observed but did not develop an excessively high block, significant hypotension or evidence of bupivacaine or opiate toxicity. Of the eight patients who required reintubation for respiratory failure, five were in the group that had unsatisfactory epidural analgesia. A further two patients had fentanyl removed from their epidural infusions as it was thought that it might have been contributing to postoperative sedation.
Non-steroidal anti-inflammatory drugs (NSAIDs) were administered to 93% of patients postoperatively to supplement analgesia. One patient developed melaena secondary to endoscopically identified gastric erosions and one patient developed the previously mentioned perforated duodenal ulcer.
At three months post discharge, respiratory function testing illustrated a significant improvement in FEV 1 , vital capacity and six minute walk testing (all P<0.001) ( Table 4) .
With univariate testing, the only predictors of length of ICU stay were the preoperative six minute walk test (P<0.04), and for requirement for reintuba-tion was increasing patient age (P<0.02) and postoperative PaO 2 /FiO 2 (P<0.01). Univariate predictors of length of hospital stay were patient age (P<0.04) and operation time (P<0.04).
After multivariate adjustment the only significant predictor of length of ICU stay was operation time (R 2 =0.25, P<0.001) and for hospital stay was duration of ICU stay (R 2 =0.36, P<0.001). There was no association between the dose of intraoperative fentanyl or midazolam and need for reintubation or length of ICU stay. There was no association between preoperative and first extubation PaCO 2 and requirement for reintubation or length of ICU stay.
DISCUSSION
Lung volume reduction surgery was pioneered in the late 1950s by Brantigan in Baltimore 6 . He postulated that in emphysematous lungs there was loss of elasticity resulting in loss of the normal outward pull on the bronchioles, causing small airway collapse during expiration. He surmised that a reduction in lung volume would restore the circumferential traction on the small airways, reducing air trapping. His original series of 33 patients had a high mortality (18%) and the procedure did not gain widespread acceptance until it was revisited by Cooper in the 1990s 6, 7 . There is some data to suggest that some centres still struggle to achieve acceptable mortality and morbidity: Medicare (U.S.A.) noted a 26% mortality from its records in 1995 8 . What constitutes acceptable mortality figures in this group of patients must be judged in comparison with similar patients who have not undergone operation. In a retrospective study comparing 22 lung volume reduction surgery candidates denied operation for funding reasons with 65 comparable operative patients, Meyers et al found a two-year survival of 82% in the operated group versus 64% for the medical group 9 . To address this issue, the National Heart, Lung and Blood Institute and the Health Care Financing Administration in the United States have organized a national registry and prospective controlled clinical trial over seven years. This will compare methods of lung volume reduction surgery to each other and to maximal medical therapy 10 .
The reasons for improvement in lung function seen after lung volume reduction surgery remain unclear. They may include restoration of remaining lung elastic recoil, improved chest wall and diaphragm mechanical function, decreased V/Q mismatch, improved right ventricular filling from a reduced tamponade effect and improved inspiratory muscle force generation [10] [11] [12] [13] .
The results of this surgical procedure at our insti- tution are similar to other reported series 4, 14 . They confirm that CO 2 elimination is impaired, yet this is well tolerated by most patients and does not routinely delay extubation. Intraoperative permissive hypercapnia as high as 120 mmHg has been accepted to minimize airway and alveolar pressure and maximise expiratory time in order to lessen the risk of dynamic hyperinflation, pneumothorax or air leak. This hypercapnia does not increase the risk of reintubation. Choice of anaesthetic agents, including avoidance of moderate doses of fentanyl or benzodiazepines, does not appear to be of major importance, provided that the anaesthetic is tailored towards early postoperative extubation. Due to the severe V/Q abnormalities seen in the lung volume reduction surgery group, pulmonary uptake and excretion of volatile agents may be unpredictable. This may lead to problems of inadequate depth of anaesthesia, risk of awareness and impaired hypoxic pulmonary vasoconstriction. This might make the use of total intravenous anaesthesia a more logical choice.
Length of operation was a significant multivariate predictor of length of ICU stay which itself was the only significant predictor of length of hospital stay. This may be because patients with more severe disease are more likely to have adhesions leading to a more difficult operative course. This results in an increased risk of lung trauma and air leak leading to a longer postoperative recovery. Persistent air leaks are a significant cause of postoperative morbidity. In our series, seven out of 11 patients with significant air leaks required reoperation and one died. Prolonged anaesthesia time may also lengthen recovery due to residual effects of anaesthetic agents. A long operation time should serve as a marker of those patients who are likely to have a more complicated postoperative course. Szekely et al identified a six-minute walk test of less than 200 m as being a correlate of prolonged hospital stay and mortality 15 . We found it to be an univariate predictor of ICU stay but not hospital stay. Because of our limited patient numbers, we felt that meaningful analyses of factors associated with mortality could not be undertaken.
Thoracic epidural analgesia is considered by some to be essential for the success of this procedure. Triantafillou recommended the best approach is to radiologically confirm epidural placement at the T3/4 level and to run a plain 0.2% bupivacaine infusion 1 . Problems of nausea with epidural fentanyl 5 µg/ml led to them discontinuing it in favour of a low dose IV morphine PCA. In our series, using lower (1 or 2 µg/ml) fentanyl concentrations, only three patients (7%) required fentanyl to be removed from their epidural infusions because of nausea. Three patients (5%) had a morphine infusion as their primary mode of analgesia; none of these patients had longer ICU stays or suffered any adverse consequences. Although this number is too small to base conclusions upon, it is possible that adequate analgesia may not require inclusion of epidural analgesia. The devastating complication of epidural haematoma and spastic paraparesis in our study reinforces awareness of potentially major morbidity after thoracic epidural catheterization.
In our experience, most analgesia problems were related to the lower end of the wound and drain tube sites. Epidural placement at higher thoracic levels tended to give poor coverage of these sites. Infiltration of intercostal catheter exit sites with local anaesthetic combined with supplemental analgesia from NSAIDs and regular paracetamol was useful in managing pain from areas not well covered by an epidural. Nearly all patients received postoperative diclofenac or indomethacin suppositories even in the presence of relative contraindications such as a history of peptic ulcer disease. One patient developed gastric erosions and another a perforated duodenal ulcer that may have been contributed to by NSAID use. Neither patient had a pre-existing history of peptic ulcer disease.
We had a high rate of pulmonary artery catheter use in our series. This was guided by North American and our local experience with pulmonary transplantation anaesthesia; we had no episode of significant pulmonary hypertension requiring vasodilator or nitric oxide therapy and we now routinely insert a central venous catheter only.
In conclusion, careful intraoperative and postoperative anaesthetic and analgesic management are essential to successful lung volume reduction surgery. Patients undergoing this procedure can be routinely extubated at the end of the operation despite the presence of significant hypercapnia. Either a volatilebased or total intravenous general anaesthetic technique can be used. This study does not demonstrate that one method is superior to another. Postoperative analgesia requires a multimodal approach, aiming to avoid respiratory depression and optimize ventilatory work. This is best managed using careful frequent review by appropriately trained anaesthetic staff from an acute pain service throughout the postoperative period. Failure to relieve pain, in association with sputum retention, leads to respiratory failure and reintubation and the resulting positive pressure ventilation contributes significantly to mortality and mor-bidity. Further study is required to show if hospital and ICU stays can be shortened with shorter operation times and whether mortality can be reduced by decreasing reintubation rates for respiratory failure.
